| Views | |
|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 113 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 2 | 4 | 6 | 2 | 9 | 6 | 0 |
| Views | |
|---|---|
| 2020_Schmiester_etal.pdf | 111 |
